Clofarabine Based Chemotherapy in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia/Lymphoma-a Single Institution Experience

被引：0

作者：

Alkhateeb, Hassan B. ^{[1
]}

Damlaj, Moussab ^{[1
]}

Lin, Tasha ^{[2
]}

Al-Kali, Aref ^{[1
]}

Sproat, Lisa ^{[3
]}

Betcher, Jeffrey Alan ^{[4
]}

Barreto, Jason N. ^{[5
]}

Hashmi, Shahrukh K. ^{[1
]}

Patnaik, Mrinal M. ^{[1
]}

Gangat, Naseema ^{[1
]}

Elliott, Michelle ^{[1
]}

Litzow, Mark R. ^{[1
]}

Hogan, William J. ^{[1
]}

机构：

[1] Mayo Clin, Div Hematol, Rochester, MN USA

[2] Mayo Clin, Dept Internal Med, Rochester, MN USA

[3] Mayo Clin Arizona, Div Hematol & Med Oncol, Scottsdale, AZ USA

[4] Mayo Clin, Pharm, Phoenix, AZ USA

[5] Mayo Clin, Dept Pharm Serv, Rochester, MN USA

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[41] Venetoclax-based salvage therapy for adult patients with relapsed/refractory acute lymphoblastic leukemia
Canaani, Jonathan
Frisch, Avraham
Pollyea, Daniel A.
Schwartz, Marc
Aumann, Shlomzion
Ganzel, Chezi
Haran, Arnon
Even-Zohar, Noa Gross
Shaulov, Adir
Vainstein, Vladimir
Moshe, Yakir
Ofran, Yishai
Wolach, Ofir
Nachmias, Boaz
EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (03) : 365 - 372
[42] The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia
McGregor, Bradley A.
Brown, Alexander W.
Osswald, Michael B.
Savona, Michael R.
AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (04) : 228 - 230
[43] Intensive salvage chemotherapy for primary refractory or first relapsed adult acute lymphoblastic leukemia:: results of a prospective trial
Martino, R
Bellido, M
Brunet, S
Altés, A
Sureda, A
Guárdia, R
Aventín, A
Nomedéu, JF
Domingo-Albós, A
Sierra, J
HAEMATOLOGICA, 1999, 84 (06) : 505 - 510
[44] Cytogenetic, immunophenotypic, and clinical correlation in adult acute lymphoblastic leukemia: A single institution's experience
Snyder, ML
Roulston, D
Ross, CW
Finn, WG
Schnitzer, B
Valdez, R
LABORATORY INVESTIGATION, 2002, 82 (01) : 264A - 265A
[45] Cytogenetic, immunophenotypic, and clinical correlation in adult acute lymphoblastic leukemia: A single institution's experience
Snyder, ML
Roulston, D
Ross, CW
Finn, WG
Schnitzer, B
Valdez, R
MODERN PATHOLOGY, 2002, 15 (01) : 264A - 265A
[46] ALLOGENEIC STEM CELL TRANSPLANTION IN RELAPSED/REFRACTORY ACUTE LEUKEMIA: A LONG TERM SINGLE INSTITUTION EXPERIENCE
Go, A.
Stiff, P. J.
Parthasarathy, M.
Rodriguez, T. E.
Smith, S. E.
Brush, M.
Kiley, K.
Payan, M.
Porter, N.
Volle, M.
Vesole, D. H.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 61 - 61
[47] FLAG-IDA in the treatment of refractory/relapsed adult acute lymphoblastic leukemia
G. Specchia
D. Pastore
P. Carluccio
A. Liso
A. Mestice
R. Rizzi
L. Ciuffreda
G. Pietrantuono
V. Liso
Annals of Hematology, 2005, 84 : 792 - 795
[48] Outcomes of children treated for relapsed or refractory acute lymphoblastic leukemia: A single tertiary care center experience
Almalki, Mosfer
Abdulatef, Mohammed
Altrabolsi, Hassan
Shubayr, Nasser
CANCER REPORTS, 2024, 7 (07)
[49] IDH2 Inhibitor Therapy in Relapsed and Refractory Acute Myeloid Leukemia: A Single Institution Experience
Li, Marissa
Morsia, Erika
Wee, Christopher E.
McCullough, Kristen
Al-Kali, Aref
Hogan, William J.
Patnaik, Mrinal M.
Tefferi, Ayalew
Gangat, Naseema
BLOOD, 2020, 136
[50] INOTUZUMAB OZAGAMICIN IS SAFE AND EFFECTIVE IN RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA: A SINGLE ITALIAN CENTER EXPERIENCE
Sartor, C.
Marconi, G.
Abbenante, M. C.
Robustelli, V.
Baldazzi, C.
Cristiano, G.
Nanni, J.
Parisi, S.
Terragna, C.
Testoni, N.
Soverini, S.
Paolini, S.
Martinelli, G.
Curti, A.
Cavo, M.
Papayannidis, C.
HAEMATOLOGICA, 2020, 105 : S95 - S95

← 1 2 3 4 5 →